Vivek Patel, MD (@vpatelmd) 's Twitter Profile
Vivek Patel, MD

@vpatelmd

Assistant Professor @VUMCHemOnc | Co-Host @TheFellowOnCall | Alum of @VUMCMedicineRes @VUMedicine @dukeu | #meded #cancer | Tweets my own

ID: 1479974548854476803

calendar_today09-01-2022 00:33:30

323 Tweet

895 Followers

205 Following

Manni Mohyuddin (@mannimd1) 's Twitter Profile Photo

Calling all physicians/advanced practice providers seeing pts with multiple myeloma! We invite you to participate in a quick survey on "Clinician Perspectives on Smoldering Myeloma." Led by Ben Derman Raj Chakraborty Eddie Cliff Survey link: bit.ly/smolderingMM #mmsm

The Fellow On Call (@thefellowoncall) 's Twitter Profile Photo

After several weeks of some amazing discussions with our special guests, it's time to chat about the role of #medonc in the management of #BreastCancer! First up, we start our discussion on early stage ER+ breast cancer. Trust us, this is a good one, y'all! #bcsm

After several weeks of some amazing discussions with our special guests, it's time to chat about the role of #medonc in the management of #BreastCancer! First up, we start our discussion on early stage ER+ breast cancer. 

Trust us, this is a good one, y'all! #bcsm
The Fellow On Call (@thefellowoncall) 's Twitter Profile Photo

Time for part ✌️of our early stage ER+ #breastcancer discussion! Let's round our great discussion, focusing on more high yield topics you need to know to care for your patients (& for exams!) #ICYMI highly recommend checking out episode 057 first! Link in bio! #BCSM #ASCO23

Time for part ✌️of our early stage ER+ #breastcancer discussion! Let's round our great discussion, focusing on more high yield topics you need to know to care for your patients (& for exams!)

#ICYMI highly recommend checking out episode 057 first!

Link in bio! #BCSM #ASCO23
The Fellow On Call (@thefellowoncall) 's Twitter Profile Photo

We are SO EXCITED to be teaming up with our friends TwoOncDocs for a special upcoming series this month following #ASCO23! To learn more about this Collaborative Series, check out our teaser: podcasts.apple.com/us/podcast/spe… Stay tuned, y'all! This is going to be 🔥!

We are SO EXCITED to be teaming up with our friends <a href="/TwoOncDocs/">TwoOncDocs</a> for a special upcoming series this month following #ASCO23! 

To learn more about this Collaborative Series, check out our teaser: podcasts.apple.com/us/podcast/spe… 

Stay tuned, y'all! This is going to be 🔥!
Vivek Patel, MD (@vpatelmd) 's Twitter Profile Photo

We had a great conversation with Katie Coleman at ASCO. Amazing patient advocate and looking forward to working on a few initiatives with her. Check out her story and listen to her podcast to get important insights from a patient perspective. Ronak H. Mistry, DO

The Fellow On Call (@thefellowoncall) 's Twitter Profile Photo

Episode 1 of our collab with our friends TwoOncDocs is now available! We talk all about the #PROSPECT Trial discussed at #ASCO23, what a "non-inferiority trial" really is, pros/cons of the study, & how this informs our mgmt! Check it out here: podcasts.apple.com/us/podcast/two…

Episode 1 of our collab with our friends <a href="/TwoOncDocs/">TwoOncDocs</a> is now available! We talk all about the #PROSPECT Trial  discussed at #ASCO23, what a "non-inferiority trial" really is, pros/cons of the study, &amp; how this informs our mgmt! Check it out here: podcasts.apple.com/us/podcast/two…
The Fellow On Call (@thefellowoncall) 's Twitter Profile Photo

Ep. 2 of our collab with our friends TwoOncDocs is now available! This time, we talk about the SWOG 1826 plenary from #ASCO23, define p-values, trial medians, the pros/cons of the trial & how this informs our mgmt of Hodgkin's lymphoma! Check it out here: podcasts.apple.com/us/podcast/the…

Ep. 2 of our collab with our friends <a href="/TwoOncDocs/">TwoOncDocs</a> is now available! This time, we talk about the SWOG 1826 plenary from #ASCO23, define p-values, trial medians, the pros/cons of the trial &amp; how this informs our mgmt of Hodgkin's lymphoma! Check it out here: podcasts.apple.com/us/podcast/the…
Mike Putman (@ebrheum) 's Twitter Profile Photo

Excited to see my perspective piece in NEJM re:“hospital problems” Have a read & thanks to all who have shared already! nejm.org/doi/full/10.10…

Excited to see my perspective piece in <a href="/NEJM/">NEJM</a> re:“hospital problems”

Have a read &amp; thanks to all who have shared already! 

nejm.org/doi/full/10.10…
The Fellow On Call (@thefellowoncall) 's Twitter Profile Photo

This week, it's all about early stage triple negative breast cancer! As always, we cover the highlights of the disease and how we got to our current treatment landscape. This episode also rounds out our early stage discussions - next up: metastatic disease Link in bio! #BCSM

This week, it's all about early stage triple negative breast cancer! As always, we cover the highlights of the disease and how we got to our current treatment landscape. 

This episode also rounds out our early stage discussions - next up: metastatic disease

Link in bio! #BCSM
Manni Mohyuddin (@mannimd1) 's Twitter Profile Photo

Daratumumab has been known to be effective in relapsed myeloma for a long time. Yet it was mostly not given to the control arm upon progression in trials of newly diagnosed myeloma. This is a preventable tragedy- that we must avoid repeating. #mmsm jamanetwork.com/journals/jaman…

Daratumumab has been known to be effective in relapsed myeloma for a long time.

Yet it was mostly not given to the control arm upon progression in trials of newly diagnosed myeloma.

This is a preventable tragedy- that we must avoid repeating.

#mmsm

jamanetwork.com/journals/jaman…
The Fellow On Call (@thefellowoncall) 's Twitter Profile Photo

Time for another "Heme Consult Series," this time focusing on the dx and mgmt of von Willebrand Disease! This week, in pt 1, we break down the approach to dx and discuss Types 1 and 3. Many find vWD mgmt confusing, but don't worry - we got you covered 😎 Link in bio!

Time for another "Heme Consult Series," this time focusing on the dx and mgmt of von Willebrand Disease! This week, in pt 1, we break down the approach to dx and discuss Types 1 and 3. 

Many find vWD mgmt confusing, but don't worry - we got you covered 😎

Link in bio!
The Fellow On Call (@thefellowoncall) 's Twitter Profile Photo

We move our #DLBCL discussion to the "primary refractory" stage in this week's new ep. What does this term mean? How do we approach this? We cover this and more! Link in bio! #lymsm

We move our #DLBCL discussion to the "primary refractory" stage in this week's new ep. What does this term mean? How do we approach this? We cover this and more!

Link in bio! #lymsm
Manni Mohyuddin (@mannimd1) 's Twitter Profile Photo

Here are my slides on a talk I gave on why there is no association between most auto-immune diseases and MGUS. And why previous studies were flawed/claimed erroneous associations. All credit to the amazing iStopMM for this. tinyurl.com/ky9smm3e Sarah Schafer MD MPH #mmsm

Here are my slides on a talk I gave on why there is no association between most auto-immune diseases and MGUS.

And why previous studies were flawed/claimed erroneous associations.

All credit to the amazing <a href="/iStopMM/">iStopMM</a> for this.

tinyurl.com/ky9smm3e

<a href="/SarahSchaferMD/">Sarah Schafer MD MPH</a> 

#mmsm
The Fellow On Call (@thefellowoncall) 's Twitter Profile Photo

🧵THE FELLOW ON CALL TWEETORIAL SERIES 🧵 1/ APPROACH TO ANEMIA👇 🎧Spotify: shorturl.at/zBMNZ 🍎Apple: shorturl.at/txFMP Website: shorturl.at/dkFL7

Vivek Patel, MD (@vpatelmd) 's Twitter Profile Photo

Really proud of two of my mentees receiving Conquer Cancer, the ASCO Foundation merit awards! Ronak Mistry for our innovative heme/onc med ed research and Morgan Zenner for our work in CART Dr. Cathy Eng @VUMC_Medicine Dr. jordan berlin Ben Ho Park @VUMCMedicineRes Ronak H. Mistry, DO

Vivek Patel, MD (@vpatelmd) 's Twitter Profile Photo

Conquer cancer awardee Morgan Zenner @VUMC_Medicine Multicenter analysis of the impact of late ICAHT after CART for large B cell lymphoma Not associated with severe infection or survival outcomes. Stop by poster 24 to learn more! Thanks to Peter Reidell UChicagoCancerCenter

Conquer cancer awardee Morgan Zenner @VUMC_Medicine 

Multicenter analysis of the impact of late ICAHT after CART for large B cell lymphoma 

Not associated with severe infection or survival outcomes. Stop by poster 24 to learn more!

Thanks to Peter Reidell <a href="/UCCancerCenter/">UChicagoCancerCenter</a>
The Fellow On Call (@thefellowoncall) 's Twitter Profile Photo

🚨Hot off the press: A simultaneous publication in JCO Oncology Practice alongside Vivek Patel, MD’s presentation highlighting the 1st cluster randomized study evaluating podcasts for heme/onc education! The outcome: The Fellow On Call and TwoOncDocs should be included for h/o fellow education!

🚨Hot off the press: A simultaneous publication in <a href="/JCOOP_ASCO/">JCO Oncology Practice</a> alongside <a href="/vpatelmd/">Vivek Patel, MD</a>’s presentation highlighting the 1st cluster randomized study evaluating podcasts for heme/onc education! 

The outcome: <a href="/TheFellowOnCall/">The Fellow On Call</a> and <a href="/TwoOncDocs/">TwoOncDocs</a> should be included for h/o fellow education!